Topline data were announced from a phase 3b trial evaluating investigational semaglutide 7.2mg in adults with obesity.

Guggenheim Securities adjusted its financial outlook for Novo Nordisk (NYSE:NVO) shares (NOVOB:DC) (NYSE: NVO), raising the price target slightly to DKK798.00 from DKK795.00. The firm maintained a Buy ...

Those in the jab trials, however, kept off between 10 and 25 per cent of their body weight over the same timeframe, depending ...

In 2024, Eli Lilly started offering single-dose vials, as opposed to the auto-injector pen that ... supply of the 5 mg dose costs $549. Ro offers a compounded version of semaglutide, the active ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected to significantly disrupt the pharmaceutical landscape in the country this ...

Creador is banking on MG’s low-cost platform to shake up key markets like North Asia and Europe. The challenge? Scaling globally while keeping MG’s lean and efficient DNA intact. Creador has ...

In 2025, MG will also begin offering new models from its freshly introduced ‘Select’ dealerships that has been conceptualised for its premium range of cars Morris Garages, commonly known as MG ...

China’s official Manufacturing Purchasing Managers' Index (PMI) eased to 50.1 in December, compared to 50.3 in the previous reading. The reading came in below the market consensus of 50.3 in the ...

Three of MG’s upcoming models are expected to be put up on display at the Bharat Mobility Global Expo 2025. MG Motor India is geared up to make a bold statement in 2025 with an impressive lineup ...